Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

NCT02433379 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02433379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02433379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
June 9, 2015
Completion date
December 6, 2019
Enrollment
1,173 (actual)
Sites
110

Conditions

As the registry lists them; a condition with its own page is linked.

low cardiac output, ventricular fibrillation, ventricular tachycardia